(Q54420300)

English

Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Dermatophagoides pteronyssinus

1 reference

based on heuristic

inferred from title

allergic asthma

1 reference

based on heuristic

inferred from title

author name string

Nhân Pham-Thi

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

Pierre Scheinmann

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

Riad Fadel

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

Anne Combebias

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

Claude Andre

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

publication date

1 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

Pediatric Allergy & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

18

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

47-57

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

Indoor allergens and asthma: report of the Third International Workshop

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Noninjection routes for immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Mechanisms of immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Immune mechanisms of allergen-specific sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Stepping down inhaled corticosteroids in asthma: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Development of child-centered disease-specific questionnaires for living with asthma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Results of a home-based environmental intervention among urban children with asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

A randomized controlled trial of mite allergen-impermeable bed covers in adult mite-sensitized asthmatics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive FcepsilonRI expression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Safety of sublingual immunotherapy in children with asthma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

The safety of sublingual-swallow immunotherapy: an analysis of published studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Identifiers

10.1111/J.1399-3038.2006.00475.X

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54420300&oldid=1525135886"